Meta-analysis of the relationship between Parkinson disease and melanoma

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neurology

• Publication date

  2011-06-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.0b013e31821e554ePMID 21646627PMCID PMC3116643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SMOKING DURATION, INTENSITY, AND RISK OF PARKINSON DISEASE

  2010cited by this paper
• Cancer risk in association with Parkinson disease: a population-based study.

  2010cited by this paper
• FAMILY HISTORY OF MELANOMA AND PARKINSON DISEASE RISK

  2010cited by this paper
• Pesticide Use and Cutaneous Melanoma in Pesticide Applicators in the Agricultural Heath Study

  2010cited by this paper
• Comorbid cancer in Parkinson's disease

  2010cited by this paper
• Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma

  2010cited by this paper
• Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease

  2010cited by this paper
• Parkinson’s disease and cancer risk: a systematic review and meta-analysis

  2010cited by this paper
• Skin cancer and Parkinson's disease

  2010cited by this paper
• Smoking duration, intensity, and risk of Parkinson disease

  2010cited by this paper
• Common pathogenic pathways in melanoma and Parkinson disease

  2010cited by this paper
• Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.

  2010cited by this paper
• No Role for Melanoma Treatment in the Association between Melanoma and Amyotrophic Lateral Sclerosis or Parkinson’s Disease

  2010cited by this paper
• Genetic determinants of hair color and parkinson's disease risk

  2009cited by this paper
• Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies

  2009cited by this paper
• Family history of melanoma and Parkinson disease risk

  2009cited by this paper
• The particular relationship between Parkinson’s disease and malignancy: a focus on skin cancers

  2009cited by this paper
• Pigmentation genes link Parkinson's disease to melanoma, opening a window on both etiologies.

  2009cited by this paper
• Skin cancers and precancerous lesions in Parkinson's disease patients

  2007cited by this paper
• Treatment with levodopa and risk for malignant melanoma

  2007cited by this paper
• A Prospective Cohort Study of Cancer Incidence Following the Diagnosis of Parkinson's Disease

  2007cited by this paper
• Gender differences in skin: a review of the literature.

  2007cited by this paper
• Point: Sunscreen Use Is a Safe and Effective Approach to Skin Cancer Prevention

  2007cited by this paper
• Prospective case–control study of nonfatal cancer preceding the diagnosis of parkinson’s disease

  2007cited by this paper
• Malignant melanoma in early Parkinson's disease: The DATATOP trial

  2007cited by this paper
• Smoking, Parkinson's Disease, and Melanoma

  2007cited by this paper
• Counterpoint: Sunscreen Use Is a Safe and Effective Approach to Skin Cancer Prevention

  2007cited by this paper
• Malignant Melanoma and Other Types of Cancer Preceding Parkinson Disease

  2006cited by this paper
• Mortality due to Amyotrophic Lateral Sclerosis and Parkinson’s Disease among Melanoma Patients

  2006cited by this paper
• Pesticide exposure and risk for Parkinson's disease

  2006cited by this paper
• Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk.

  2006cited by this paper
• Risk of cancer after the diagnosis of Parkinson's disease: A historical cohort study

  2005cited by this paper
• Amyotrophic Lateral Sclerosis Mortality in 1.9 Million US Cancer Survivors

  2005cited by this paper
• Atypical cancer pattern in patients with Parkinson's disease

  2004cited by this paper
• Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity.

  2003cited by this paper
• Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?

  2003cited by this paper
• A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study.

  2002cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Nonfatal Cancer Preceding Parkinson’s Disease: A Case-Control Study

  2002cited by this paper
• Molecular control of neural crest formation, migration and differentiation.

  2000cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Occurrence of different cancers in patients with Parkinson's disease

  1995cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper

• Linking Parkinson’s disease and melanoma: the impact of copper-driven cuproptosis and related mechanisms

  2025cites this paper
• Common genetic basis and causality between central nervous system disease and cancer.

  2025cites this paper
• Concomitant Pathologies and Their Impact on Parkinson Disease: A Narrative Overview of Current Evidence

  2025cites this paper
• Risk factors for actinic keratosis, non‐melanoma skin cancer and cutaneous malignant melanoma in persons with and without Parkinson's disease: A cross‐sectional study

  2024cites this paper
• New Aspects Regarding the Fluorescence Spectra of Melanin and Neuromelanin in Pigmented Human Tissue Concerning Hypoxia

  2024cites this paper
• Hair color, family history of melanoma, and the risk of Parkinson's disease: An analysis update.

  2023cites this paper
• Cutaneous malignancies in patients with Parkinson’s disease at a dermato-oncological university centre in Hungary

  2023influential citation
• Glycolipids in Parkinson's disease: beyond neuronal function

  2023cites this paper
• Extracellular transportation of α-synuclein by HLA class II molecules.

  2022cites this paper
• Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease

  2022cites this paper
• Particulate Matter Exacerbates the Death of Dopaminergic Neurons in Parkinson’s Disease through an Inflammatory Response

  2022cites this paper
• Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry

  2022cites this paper
• Common Pathogenetic Mechanisms Underlying Aging and Tumor and Means of Interventions

  2022cites this paper
• Skin Conditions and Movement Disorders: Hiding in Plain Sight

  2022cites this paper
• SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma

  2022cites this paper
• SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma

  2022cites this paper
• Improving therapeutic synergy score predictions with adverse effects using multi-task heterogeneous network learning

  2022influential citation
• Gender-Dependent Specificities in Cutaneous Melanoma Predisposition, Risk Factors, Somatic Mutations, Prognostic and Predictive Factors: A Systematic Review

  2021cites this paper
• Risk of Nonmelanoma Skin Cancers and Parkinson’s Disease—Meta-Analysis and Systematic Review

  2021cites this paper
• Contribution of rare variant associations to neurodegenerative disease presentation

  2021cites this paper
• Parkinson’s Disease as a Risk Factor for Melanoma: A Review

  2021influential citation
• Increased Frequency of Dermatological Diseases in Parkinson's Patients

  2021cites this paper
• Association Analysis of Polymorphisms in BIN1, MC1R, STARD6 and PVRL2 with Mild Cognitive Impairment in Elderly Carrying APOE ε4 Allele

  2021cites this paper
• NDT_A_296144 1125..1133

  2021cites this paper
• Contribution of rare variant associations to neurodegenerative disease presentation

  2021cites this paper
• Cancer risk in Parkinson disease: An updated systematic review and meta‐analysis

  2021cites this paper
• Transcriptomic profiles in Parkinson’s disease

  2020cites this paper
• Cancer and Parkinson's Disease: Common Targets, Emerging Hopes

  2020cites this paper
• Emerging Evidences for an Implication of the Neurodegeneration-Associated Protein TAU in Cancer

  2020cites this paper
• Dermatological Manifestations of Parkinson's Disease: Clues for Diagnosis

  2020cites this paper
• Tau: At the Interface Between Neurodegeneration and Cancer?

  2020cites this paper
• The Links between Parkinson’s Disease and Cancer

  2020cites this paper
• Bidirectional Relation Between Parkinson's Disease and Glioblastoma Multiforme

  2020cites this paper
• Targeted sequencing of Parkinson's disease loci genes highlights SYT11, FGF20 and other associations

  2020cites this paper
• Parkinson’s disease and skin cancer risk: a nationwide population‐based cohort study in Korea

  2020cites this paper
• Association Between Parkinson’s Disease and Melanoma: Putting the Pieces Together

  2020cites this paper
• The neurobehavioral implications of the brain and microbiota interaction.

  2020cites this paper
• Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease

  2019cites this paper
• Parkinson’s Disease, Lithium and Stem Cells

  2019cites this paper
• High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity.

  2019cites this paper
• Novel Functions of the Neurodegenerative-Related Gene Tau in Cancer

  2019cites this paper
• In Small Study, Parkinson's Disease Patients with LRRK2 Mutation Have Elevated Risk for Different Cancers

  2019cites this paper
• Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls

  2019cites this paper
• Essential Tremor and Parkinson’s Disease: Exploring the Relationship

  2019cites this paper
• Serum Amyloid Alpha Is Downregulated in Peripheral Tissues of Parkinson’s Disease Patients

  2019cites this paper
• Cancer risk in patients with Parkinson's disease in South Korea: A nationwide, population-based cohort study.

  2019cites this paper
• Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach

  2019cites this paper
• Discovery of a novel tumor suppressor from the autophagy regulatory network: LRRK2 in lung adenocarcinoma

  2019cites this paper
• Overlapping genetic architecture between Parkinson disease and melanoma

  2019cites this paper
• Clinical Epidemiology of Melanoma

  2018cites this paper
• Comment on: "Cancer in Parkinson's disease".

  2018cites this paper
• Skin Disease and Neurological Conditions of the Elderly

  2018cites this paper
• Skin disorders in Parkinson's disease

  2018cites this paper
• Parkin in Parkinson’s Disease and Cancer: a Double-Edged Sword

  2018cites this paper
• Parkinson’s Disease, Melanoma, and Keratinocyte Carcinoma: A Population-Based Study

  2018cites this paper
• Neurodegenerative Protein Misfolding Disorders and the Skin

  2018cites this paper
• Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.

  2018cites this paper
• Parkinson’s Disease: Contemporary Concepts and Clinical Management

  2018cites this paper
• Low cancer prevalence in polyglutamine expansion diseases

  2017cites this paper
• A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer’s Disease Risk

  2017cites this paper
• Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies

  2017cites this paper
• Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation

  2017cites this paper
• Ubiquitination in melanoma pathogenesis and treatment

  2017cites this paper
• LRRK2 interacts with ATM and regulates Mdm2–p53 cell proliferation axis in response to genotoxic stress

  2017cites this paper
• Looking beyond the brain to improve the pathogenic understanding of Parkinson’s disease: implications of whole transcriptome profiling of Patients’ skin

  2017cites this paper
• Red hair, MC1R variants, and risk for Parkinson's disease – a meta‐analysis

  2017cites this paper
• Skin disorders in Parkinson’s disease: potential biomarkers and risk factors

  2017cites this paper
• Duration of Analgesic Use and Risk of Hearing Loss in Women

  2017cites this paper
• Biological and Clinical Implications of Comorbidities in Parkinson’s Disease

  2017cites this paper
• The melanoma‐linked “redhead” MC1R influences dopaminergic neuron survival

  2017influential citation
• ATP13A2/PARK9 regulates endo‐/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2‐mediated scaffolding function

  2017cites this paper
• Skin Cancer: Genetics, Immunology, Treatments, and Psychological Care

  2017cites this paper
• Red hair , MC 1 R variants , and risk for Parkinson ' s disease – a meta # analysis

  2017cites this paper
• Parkinson Disease and Melanoma: Confirming and Reexamining an Association

  2017cites this paper
• Parkinson disease (PARK) genes are somatically mutated in cutaneous melanoma

  2016cites this paper
• Risk of lung cancer in Parkinson's disease

  2016cites this paper
• Cutaneous Adverse Effects of Neurologic Medications

  2016cites this paper
• PARKIN Inactivation Links Parkinson's Disease to Melanoma.

  2016cites this paper
• Parkinson’s Disease: Assay of Phosphorylated α-Synuclein in Skin Biopsy for Early Diagnosis and Association with Melanoma

  2016cites this paper
• Cutaneous malignant melanoma and Parkinson disease: Common pathways?

  2016cites this paper
• Glucosylceramidases and malignancies in mammals.

  2016cites this paper
• Neuromelanin MR imaging in Parkinson ’ s disease

  2016cites this paper
• Cutaneous malignant melanoma and Parkinson ' s disease : common pathways ? Running head : Parkinson ' s disease and malignant melanoma

  2016cites this paper
• Genetic analysis of MC1R variants in Chinese Han patients with sporadic Parkinson's disease.

  2016cites this paper
• Environmental risk factors and Parkinson's disease: An umbrella review of meta-analyses.

  2016cites this paper
• The role of the melanoma gene MC1R in Parkinson disease and REM sleep behavior disorder.

  2016cites this paper
• Epidemiology of Parkinson's Disease: A Population-Based Study in Primary Care in Italy

  2016cites this paper
• Epidemiology of Parkinson's disease.

  2016cites this paper
• Non-genetic risk factors for cutaneous melanoma and keratinocyte skin cancers: An umbrella review of meta-analyses.

  2016cites this paper
• Identifying Subjects At Risk of Parkinson’s Disease in the Community: PREDICT-PD

  2016cites this paper
• The epidemiology of Parkinson's disease: risk factors and prevention.

  2016cites this paper
• Parkinsonism and Related Disorders

  2016cites this paper
• Is fresh frozen plasma as good as prothrombin complex concentrate for vitamin K antagonist reversal in acute intracerebral hemorrhage?

  2016cites this paper
• Parkin Somatic Mutations Link Melanoma and Parkinson's Disease.

  2016influential citation
• Increased Odds of Melanoma: Parkinson's Disease, Essential Tremor, Dystonia versus Controls

  2016cites this paper
• Cancer incidence among Parkinson's disease patients in a 10-yrs time-window around disease onset: A large-scale cohort study.

  2016cites this paper
• Associations between cancer and Parkinson's disease in U.S. elderly adults.

  2016cites this paper
• Chronic Inflammation Links Cancer and Parkinson’s Disease

  2016cites this paper
• Reply

  2016cites this paper
• Lack of association between MC1R variants and Parkinson disease in European descent

  2016cites this paper